# Study to Evaluate Pharmacokinetics of A Modified Release Formulation of PF-06650833 in Healthy Subjects

> **NCT02609139** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 18 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** PF-06650833
- **DRUG:** PF-06650833
- **DRUG:** PF-06650833
- **DRUG:** PF-06650833
- **DRUG:** PF-06650833
- **DRUG:** PF-06650833

## Key facts

- **NCT ID:** NCT02609139
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11
- **Primary completion:** 2016-02
- **Final completion:** 2016-02
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2016-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02609139

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02609139, "Study to Evaluate Pharmacokinetics of A Modified Release Formulation of PF-06650833 in Healthy Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02609139. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*